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Association of a genetic variant in the adiponectin gene with persistent hypertension in 
Hong Kong Chinese
KL Ong, M Li, AWK Tso, A Xu, SS Cherny, PC Sham, HF Tse, BMY Cheung, KSL Lam
Department of Medicine, The University of Hong Kong, Hong Kong
Introduction: We have previously found that low plasma adiponectin level was predictive of the development of 
hypertension in our local Chinese population. In this study, we investigated the associations of genetic variants 
in the adiponectin gene with plasma adiponectin level and hypertension.
Methods: A total of 14 single nucleotide polymorphisms (SNPs) were genotyped by the MassARRAY system 
(Sequenom, San Diego, CA) in 1936 subjects from the Hong Kong Cardiovascular Risk Factor Prevalence Study–
2 (CRISPS-2). Plasma adiponectin level was measured by an in-house sandwich enzyme-linked immunosorbent 
assay in 1650 subjects. 
Results: Plasma adiponectin level was significantly associated with four SNPs, rs12495941 (beta=0.100, P<0.0001), 
rs182052 (beta= –0.095, P<0.0001), -10677C>T (beta=0.067, P=0.0017), and rs266729 (beta=  –0.071, P=0.0008). These 
SNPs were not associated with prevalent or incident hypertension among all the 1936 subjects. However, the 
SNP rs266729 was significantly associated with hypertension (odds ratio=1.49; 95% CI, 1.13-1.95; P=0.0044) and 
diastolic blood pressure (beta=0.113, P=0.018) in a sub-cohort of 1616 subjects who were normotensive or 
hypertensive for the whole 6.4-year follow-up period. In this sub-cohort, this SNP (odds ratio=1.39, P=0.020) was 
independently associated with hypertension in stepwise logistic regression. No significant sex interaction was 
found for the SNP with adiponectin level and hypertension. 
Conclusion: Several genetic variants in the adiponectin gene influenced plasma adiponectin levels in our 
population and the SNP 266729 was associated with persistent hypertension in this population. Further studies 
on the role of genetic variants in hypertension are warranted.
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Introduction: Elevated plasma fibrinogen level is associated with cardiovascular diseases. Two prospective 
studies in Caucasian populations showed positive association of plasma fibrinogen level with incident 
hypertension in men, but not in women. Single nucleotide polymorphisms (SNPs) in the gene encoding the 
fibrinogen beta chain (FGB) have been reported to be associated with plasma fibrinogen level. We therefore 
investigated the association of genetic variants in the FGB gene with hypertension.
Methods: Three tagging SNPs were genotyped in subjects from the Hong Kong Cardiovascular Risk Factor 
Prevalence Study cohort with a median follow-up period of 6.4 years. Genotyping was performed by the 
MassARRAY system (Sequenom, San Diego, CA) in 1294 subjects who had plasma fibrinogen level measured. 
Results: The SNP rs4220 showed significant association with plasma fibrinogen level (beta=0.144, P<0.001 at 
baseline and beta=0.130, P<0.001 at follow-up). This SNP was also significantly associated with hypertension 
(odds ratio=1.49, P=0.004 at baseline and odds ratio=1.32, P=0.013 at follow-up). Among subjects without 
hypertension at baseline, this SNP was associated with incident hypertension in men (odds ratio=1.52, P=0.023), 
but not in women. This SNP showed a marginal non-significant sex interaction for incident hypertension 
(P=0.076). 
Conclusion: As SNP rs4220 in the FGB gene is associated with both fibrinogen level and hypertension, fibrinogen 
may play a causal role in the development of hypertension development, especially in men. 
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